Friday, May 17 2013 9:05 PM EDT2013-05-18 01:05:04 GMT
The Southwest Louisiana Tea Party movement began picking up steam in 2009 as members from throughout the five parish area began gathering for rallies and becoming more visible and involved in local governmentMore >>
The Southwest Louisiana Tea Party movement began picking up steam in 2009 as members from throughout the five-parish area began gathering for rallies and becoming more visible and involved in local government and the political scene.More >>
Friday, May 17 2013 8:55 PM EDT2013-05-18 00:55:58 GMT
An arrest has been made in the 1962 death of Mary Horton Vail. Vail was found dead in the Calcasieu River in October 1962, her husband, Felix Vail, claimed she was the victim of a boating accident. TheMore >>
Mary Horton Vail was found dead in the Calcasieu River in October 1962. Her husband, Felix Vail, claimed she was the victim of a boating accident.More >>
Friday, May 17 2013 6:17 PM EDT2013-05-17 22:17:04 GMT
Friday marks the anniversary of the first woman reported missing in the Jeff Davis Eight case. On May 17, 2005, 28-year-old Loretta Chaisson Lewis went missing. Three days later, her body was found floatingMore >>
Friday marks the anniversary of the first woman reported missing in the Jeff Davis Eight case.More >>
Friday, May 17 2013 5:47 PM EDT2013-05-17 21:47:38 GMT
More than 825 students - the largest graduating class in McNeese State University history - are expected to receive degrees at the university's spring commencement ceremony at 10 a.m. Saturday, May 18,More >>
More than 825 students - the largest graduating class in McNeese State University history - are expected to receive degrees at the university's spring commencement ceremony at 10 a.m. Saturday at Burton Coliseum.More >>
Friday, May 17 2013 5:44 PM EDT2013-05-17 21:44:31 GMT
In an area prone to hurricanes, flood insurance is important for Louisiana residents. Calcasieu Parish became a part of the National Flood Insurance program in 1978. By participating in the program,More >>
As a way to continue offering flood insurance, Congress passed the Biggert Waters Act in 2012. More >>
Local News, Weather, Traffic, Sports, Stocks, Movies on your Cell PhoneMore >>
Get local news, weather, sports, and video on your mobile device.More >>
Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.
NEW YORK, Feb. 18, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Chlamydia trachomatis (CT) is an intracellular Gram-negative bacterium and a leading cause worldwide of sexually-transmitted disease and preventable blindness. The pathogen is a major cause of serious reproductive complications in the female with outcomes such as pelvic inflammatory disease (PID) and ectopic pregnancies.
Although diagnosed infections with Chlamydia trachomatis are curable with antibiotic therapy the vast majority infections are "silent" and unrecognized. This is of concern due to continued transmission especially among individuals below 30 years of age. Prophylatic vaccines could prevent CT primary infection, reinfection or lessen the incidence and severity of PID, or similar long-term sequelae. A key question for vaccine manufacturers is whether a CT vaccine would be deployed alongside HPV vaccines in the preadolescent population, thus providing a sizeable commercial opportunity.
This MarketVIEW product gives a comprehensive vaccine value ($USD/volume (000s) forecast for a putative CT vaccine until 2035. The model includes LO/BASE/HI forecast scenarios so the user can visualize the commercial impact of differing targetting/competitive and pricing scenarios. This product is an essential component of any commercial opportunistic assessment focused on new adolescent vaccines.
THIS PRODUCT IS A SUMMARY PRESENTATION + MODEL Contents – Summary presentation (MS PowerPoint based)Executive SummaryCommercial model – key outputsTotal available demand: Chlamydia vaccine, global, (000s doses)Total available demand: Chlamydia vaccine, high-income markets, (000s doses)Total available demand: Chlamydia vaccine, emerging markets, (000s doses)Total available market: Chlamydia vaccine, global, ($ 000s)Total available market: Chlamydia vaccine, by market, ($ 000s)Total available market: Chlamydia vaccine, price sensitivity analysis, ($ 000s)Chlamydia vaccine: country volume analysis, 2025 (000s doses)Chlamydia vaccine: country value analysis, 2025 ($ 000s)The role of a CT vaccineCommercial model – key assumptionsPricingModel forecast comparisons: June 2011 v currentChlamydia vaccine opportunity: target product profileOverall commercial model assumptions per countryChlamydia trachomatis: brief backgroundClinical featuresChlamydia trachomatis: natural history of infectionChlamydia trachomatis: global incidenceChlamydia trachomatis: global prevalenceUS epidemiologyUK epidemiologyReasons for increasing incidencePotential impact of a CT vaccineCompetitor landscape: overviewCompetitive environment: major playersChlamydia trachomatis vaccine – HPV, a relevant case study?HPV vaccines: analysis of country uptakeBibliographyDisclaimerAbout VacZine Analytics
PAGES: ~57 MS PowerPoint slides, fully referenced/sourced. Available in .pdf form